Literature DB >> 20142475

Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486.

Eric M Small1, Jason R O'Rourke, Viviana Moresi, Lillian B Sutherland, John McAnally, Robert D Gerard, James A Richardson, Eric N Olson.   

Abstract

microRNAs (miRNAs) play key roles in modulating a variety of cellular processes through repression of mRNA targets. In a screen for miRNAs regulated by myocardin-related transcription factor-A (MRTF-A), a coactivator of serum response factor (SRF), we discovered a muscle-enriched miRNA, miR-486, controlled by an alternative promoter within intron 40 of the Ankyrin-1 gene. Transcription of miR-486 is directly controlled by SRF and MRTF-A, as well as by MyoD. Among the most strongly predicted targets of miR-486 are phosphatase and tensin homolog (PTEN) and Foxo1a, which negatively affect phosphoinositide-3-kinase (PI3K)/Akt signaling. Accordingly, PTEN and Foxo1a protein levels are reduced by miR-486 overexpression, which, in turn, enhances PI3K/Akt signaling. Similarly, we show that MRTF-A promotes PI3K/Akt signaling by up-regulating miR-486 expression. Conversely, inhibition of miR-486 expression enhances the expression of PTEN and Foxo1a and dampens signaling through the PI3K/Akt-signaling pathway. Our findings implicate miR-486 as a downstream mediator of the actions of SRF/MRTF-A and MyoD in muscle cells and as a potential modulator of PI3K/Akt signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142475      PMCID: PMC2840099          DOI: 10.1073/pnas.1000300107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Actin dynamics control SRF activity by regulation of its coactivator MAL.

Authors:  Francesc Miralles; Guido Posern; Alexia-Ileana Zaromytidou; Richard Treisman
Journal:  Cell       Date:  2003-05-02       Impact factor: 41.582

Review 2.  Sizing up the heart: development redux in disease.

Authors:  Eric N Olson; Michael D Schneider
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

3.  Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.

Authors:  Christopher L Antos; Timothy A McKinsey; Norbert Frey; William Kutschke; John McAnally; John M Shelton; James A Richardson; Joseph A Hill; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

4.  Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways.

Authors:  Michael A Crackower; Gavin Y Oudit; Ivona Kozieradzki; Renu Sarao; Hui Sun; Takehiko Sasaki; Emilio Hirsch; Akira Suzuki; Tetsuo Shioi; Junko Irie-Sasaki; Rajan Sah; Hai-Ying M Cheng; Vitalyi O Rybin; Giuseppe Lembo; Luigi Fratta; Antonio J Oliveira-dos-Santos; Jeffery L Benovic; C Ronald Kahn; Seigo Izumo; Susan F Steinberg; Matthias P Wymann; Peter H Backx; Josef M Penninger
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

5.  The human ankyrin-1 gene is selectively transcribed in erythroid cell lines despite the presence of a housekeeping-like promoter.

Authors:  P G Gallagher; M Romana; W T Tse; S E Lux; B G Forget
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

6.  An alternate promoter directs expression of a truncated, muscle-specific isoform of the human ankyrin 1 gene.

Authors:  P G Gallagher; B G Forget
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

7.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle.

Authors:  A Musarò; K McCullagh; A Paul; L Houghton; G Dobrowolny; M Molinaro; E R Barton; H L Sweeney; N Rosenthal
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

8.  Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy.

Authors:  Ka-Man V Lai; Michael Gonzalez; William T Poueymirou; William O Kline; Erqian Na; Elizabeth Zlotchenko; Trevor N Stitt; Aris N Economides; George D Yancopoulos; David J Glass
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

9.  Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.

Authors:  Marco Sandri; Claudia Sandri; Alex Gilbert; Carsten Skurk; Elisa Calabria; Anne Picard; Kenneth Walsh; Stefano Schiaffino; Stewart H Lecker; Alfred L Goldberg
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

10.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

Authors:  Trevor N Stitt; Doreen Drujan; Brian A Clarke; Frank Panaro; Yekatarina Timofeyva; William O Kline; Michael Gonzalez; George D Yancopoulos; David J Glass
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

View more
  196 in total

1.  MicroRNAs and exercise-induced skeletal muscle adaptations.

Authors:  Micah J Drummond
Journal:  J Physiol       Date:  2010-10-15       Impact factor: 5.182

2.  Regulation of miRNAs in human skeletal muscle following acute endurance exercise and short-term endurance training.

Authors:  Aaron P Russell; Severine Lamon; Hanneke Boon; Shogo Wada; Isabelle Güller; Erin L Brown; Alexander V Chibalin; Juleen R Zierath; Rod J Snow; Nigel Stepto; Glenn D Wadley; Takayuki Akimoto
Journal:  J Physiol       Date:  2013-06-24       Impact factor: 5.182

3.  MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1.

Authors:  Aránzazu Chamorro-Jorganes; Elisa Araldi; Luiz O F Penalva; Devraj Sandhu; Carlos Fernández-Hernando; Yajaira Suárez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 4.  MicroRNAs in skeletal myogenesis.

Authors:  Yejing Ge; Jie Chen
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

5.  Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis.

Authors:  Yong Zhou; Xiangwei Huang; Louise Hecker; Deepali Kurundkar; Ashish Kurundkar; Hui Liu; Tong-Huan Jin; Leena Desai; Karen Bernard; Victor J Thannickal
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

Review 6.  Mechanisms of muscle wasting in chronic kidney disease.

Authors:  Xiaonan H Wang; William E Mitch
Journal:  Nat Rev Nephrol       Date:  2014-07-01       Impact factor: 28.314

7.  Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle.

Authors:  Daohong Chen; Chirayu P Goswami; Riesa M Burnett; Manjushree Anjanappa; Poornima Bhat-Nakshatri; William Muller; Harikrishna Nakshatri
Journal:  Cancer Res       Date:  2014-06-30       Impact factor: 12.701

8.  MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc.

Authors:  Rana Ahmed Youness; Hend Mohamed El-Tayebi; Reem Amr Assal; Karim Hosny; Gamal Esmat; Ahmed Ihab Abdelaziz
Journal:  Oncol Lett       Date:  2016-07-27       Impact factor: 2.967

9.  A Novel Regulatory Axis, CHD1L-MicroRNA 486-Matrix Metalloproteinase 2, Controls Spermatogonial Stem Cell Properties.

Authors:  Shan-Shan Liu; Eithne Margaret Maguire; Yin-Shan Bai; Li Huang; Yurong Liu; Liping Xu; Iliana Fauzi; Shou-Quan Zhang; Qingzhong Xiao; Ning-Fang Ma
Journal:  Mol Cell Biol       Date:  2019-02-04       Impact factor: 4.272

10.  miR-486 sustains NF-κB activity by disrupting multiple NF-κB-negative feedback loops.

Authors:  Libing Song; Chuyong Lin; Hui Gong; Chanjuan Wang; Liping Liu; Jueheng Wu; Sha Tao; Bo Hu; Shi-Yuan Cheng; Mengfeng Li; Jun Li
Journal:  Cell Res       Date:  2012-12-18       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.